GlassScriptPhysician profile
Anthony Camarda
NPI 1316436561
$6,608.11
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,811 · 2021: $2,638 · 2022: $1,935 · 2023: $69.39 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,413.40 | 2019-2021 | |
| Supreme Orthopedic Systems, LLC | $1,645.73 | 2021-2022 | |
| Arthrex, INC. | $1,478.08 | 2022 | |
| Smith+Nephew, INC. | $385.69 | 2019-2022 | |
| Horizon Therapeutics Plc | $255.29 | 2019 | |
| Stryker Corporation | $112.05 | 2023-2025 | Ortholoc 2 Lapifuse, Fuseforce |
| Medical Device Business Services, INC. | $111.82 | 2025 | Na |
| Zimmer Biomet Holdings, INC. | $106.46 | 2021 | |
| Medartis INC. | $45.98 | 2021 | |
| Advanced Oxygen Therapy INC. | $41.91 | 2021 | |
| Kuros Biosciences USA, INC | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Camarda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.